AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States SAN JOSE, Calif., March 24, 2020 — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the allowance […]
Anpac Technology USA (Anpac Bio)
3 Spring House Innovation Park, Suite 150
Ambler, PA 19002
Email: [email protected]
Phone Number: +1 (267) 810-6776
Anpac Bio-Medical Science Co., Ltd.
Anpac Bio is a biotechnology company focusing on early cancer screening and detection and marketing a suite of cancer detection tests, including CDA (Cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented Cancer Differentiation Analysis (CDA) technology and proprietary cancer-detection device.